ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

JUDELLA HADDAD-LACLE M.D.

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,122Medicare Part D Prescriptions Filled, Including Refills

Rank: 171 out of 3593

$986K Total Retail Price of All Prescriptions

Rank: 136 out of 3593

806 Patients Receiving at Least One Drug in Part D
55%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 806 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

31% of this provider’s 806 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 10,957 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
HYDROCODONE-ACETAMINOPHEN 1,321 618 S3 1 7
AMLODIPINE BESYLATE 855 600 2 3
LISINOPRIL 743 462 3 2
HYDROCHLOROTHIAZIDE 612 461 4 10
LEVOTHYROXINE SODIUM 545 420 5 4
NEXIUM 515 338 6 36
CRESTOR 513 351 7 21
PRAVASTATIN SODIUM 412 327 8 13
LOSARTAN POTASSIUM 388 305 9 14
METOPROLOL TARTRATE 358 244 10 8
OMEPRAZOLE 356 200 11 5
GABAPENTIN 324 186 12 16
METFORMIN HCL 306 178 13 6
FUROSEMIDE 301 190 14 9
SIMVASTATIN 280 127 15 1
METFORMIN HCL ER 234 149 16 67
POTASSIUM CHLORIDE 229 132 17 24
ALENDRONATE SODIUM 208 169 18 22
RAMIPRIL 207 144 19 92
ZOLPIDEM TARTRATE 205 104 20 12
CITALOPRAM HBR 200 98 21 25
GLYBURIDE 184 100 R 22 55
FLUTICASONE PROPIONATE 180 93 23 32
TRAMADOL HCL 180 122 23 17
ADVAIR DISKUS 167 94 25 47
RANITIDINE HCL 162 106 26 27
CARVEDILOL 157 95 27 23
METOPROLOL SUCCINATE 152 88 28 19
INSULIN SYRINGE 147 97 29 91
XOPENEX HFA 141 80 30 343
FELODIPINE ER 136 105 31 229
SERTRALINE HCL 133 42 32 28
OXYCODONE HCL 126 34 S2 33 59
CLONIDINE HCL 126 77 33 41
LANTUS 126 79 33 57
SINGULAIR 122 72 36 77
TRAZODONE HCL 122 67 36 53
WARFARIN SODIUM 121 67 38 18
KLOR-CON 10 114 101 39 114
CYCLOBENZAPRINE HCL 113 39 R 40 72
OXYCODONE HCL-ACETAMINOPHEN 111 61 S2 41 82
ISOSORBIDE MONONITRATE ER 110 78 42 61
MORPHINE SULFATE ER 98 22 S2 43 108
IBUPROFEN 97 47 44 43
TIZANIDINE HCL 95 24 45 120
ATORVASTATIN CALCIUM 94 64 46 15
AMITRIPTYLINE HCL 91 56 R 47 90
PLAVIX 91 63 47 42
FLUOXETINE HCL 90 28 49 60
METHOCARBAMOL 89 39 R 50 185
AZITHROMYCIN 88 55 51 34
PAROXETINE HCL 87 58 52 62
LYRICA 84 38 53 105
ATENOLOL 83 64 54 11
CELEBREX 82 81 55 100
GLIPIZIDE 80 50 56 40
NOVOLIN N 79 53 57 340
CLOPIDOGREL 77 44 58 30
PREMARIN 75 56 R 59 204
NOVOLOG 67 35 60 134
MELOXICAM 67 22 60 29
LIPITOR 65 45 62 136
GLIPIZIDE ER 65 41 62 101
MONTELUKAST SODIUM 64 38 64 151
PHENYTOIN SODIUM EXTENDED 64 53 64 165
VENTOLIN HFA 61 22 66 80
ACTOS 61 49 66 133
DIOVAN 60 43 68 46
BUSPIRONE HCL 60 33 68 156
TRIAMCINOLONE ACETONIDE 60 42 68 119
DILTIAZEM ER 59 59 71 194
NAPROXEN 58 38 72 68
TERAZOSIN HCL 58 37 72 115
TOPROL XL 58 40 72 390
SPIRIVA 57 21 75 87
ALLOPURINOL 57 32 75 35
PROAIR HFA 54 22 77 54
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 22 77 26
HYDROXYZINE HCL 52 0 R 79 196
SPIRONOLACTONE 51 27 80 86
NASONEX 50 29 81 192
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 1, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.